Skip to main navigation Skip to search Skip to main content

Long Term Outcomes Associated with Use of Intramuscular Interferon beta-1a in the New York State Multiple Sclerosis Consortium

Project: Research

Project Details

StatusFinished
Effective start/end date04/1/16 → 03/30/21

Funding

  • Biogen MA Incorporated: $149,346.00